Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril…

By C. Mogensen, S. Neldam, I. Tikkanen, S. Oren, R. Viskoper, R. Watts, M. Cooper. British medical journal, 2000

1,064 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology

View Paper: https://www.semanticscholar.org/paper/6020522b4a0d53ca7dceea5f88f75bb498fa5a9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. J. Forbes
2. S. Laurent
3. M. Cooper

In Endocrinology, Diabetes and Metabolism

1. J. Forbes
2. M. Cooper

Citations in the corpus

• Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes (2008, background): “To date, the most effective treatments for progressive diabetic nephropathy appear to be antihypertensive agents, particularly those that target the reninangiotensin system (RAS), such as ACE inhibitors, angiotensin receptor-1 antagonists, or their combination (2).”
• 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, result): “(446) Other studies have shown a greater antiproteinuric action of the combination, associated, however, with a greater blood pressure reduction; (447,448) indeed, when the ACE inhibitor dose was titrated to obtain the same blood pressure decrease as the combination, no difference in the antiprotein”